During the past decade, Metrolina Nephrology Associates, PA conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metrolina Nephrology Associates, PA" #1 sponsor was "Keryx Biopharmaceuticals" with 3 trials, followed by "Reata Pharmaceuticals, Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored, "CareDx" with 1 trials sponsored and "Complexa, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metrolina Nephrology Associates, PA" #1 collaborator was "Arkana Labs" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Kidney Research Network, formerly NephCure Accelerating Cures Institute" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "MicroConstants" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Metrolina Nephrology Associates, PA" are "Autosomal Dominant Polycystic Kidney" (2 trials), "Chronic Kidney Disease (CKD)" (2 trials), "Chronic Kidney Diseases" (2 trials), "Hyperphosphatemia" (2 trials) and "Kidney Failure" (2 trials). Many other conditions were trialed in "Metrolina Nephrology Associates, PA" in a lesser frequency.

Most popular intervention types in "Metrolina Nephrology Associates, PA" are "Drug" (10 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Participating Site's standard practice" (2 trials), "SRM003" (2 trials), "AND017" (1 trials), "Acthar Gel" (1 trials) and "Analytic platform (IBox)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Metrolina Nephrology Associates, PA" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Metrolina Nephrology Associates, PA". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Metrolina Nephrology Associates, PA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Metrolina Nephrology Associates, PA, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".